Concepedia

Jonathan Appleby

JA

9

Publications

684

Citations

9

H-Index

2006

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

The San Raffaele Telethon Institute for Gene Therapy

Vita-Salute San Raffaele University

GlaxoSmithKline (United States)

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

Jonathan Appleby is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pharmacology, and neurology.

Top concepts

Publications per year

2006–2018

9

Publications

9

The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans

Boris A. Chizh, M. O'Donnell, Antonella Napolitano et al. · Pain · 2007 · 244 citations

Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency

Maria Pia Cicalese, Francesca Ferrua, Laura Castagnaro et al. · Blood · 2016 · 212 citations · Full text

The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission

G.A. Lambert, Janet L. Davis, Jonathan Appleby et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2009 · 62 citations

, , +6

Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety

Maria Pia Cicalese, Francesca Ferrua, Laura Castagnaro et al. · Molecular Therapy · 2018 · 59 citations · Full text

Gene therapy in rare diseases: the benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID

Heide A. Stirnadel-Farrant, Mahesh Kudari, Nadia Garman et al. · Orphanet Journal of Rare Diseases · 2018 · 41 citations · Full text

Rows per page

1–5 of 9